Decitabine/cedazuridine, sold under the brand name Inqovi, is a fixed-dose combination medication for the treatment of adults with myelodysplastic syndromes and chronic myelomonocytic leukemia. Reference standards of Cedazuridine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Cedazuridine - API Standards [catalogue_number] => PA 03 4460000 [category_ids] => ,76,78,70,82, [chemical_name] => [weight] => 266.2 [form] => C9H12F2N2O5 [cas] => 1141397-80-9 [pslug] => 1141397-80-9-cedazuridine-api-pa034460000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 03 4460000
CAS :
Molecular Formula : C9H12F2N2O5
Molecular Weight : 266.2
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
